Search results
Results from the WOW.Com Content Network
Dietitians share which foods to eat and avoid to restore a healthy gut and avoid side effects. Antibiotics can cause nausea, diarrhea and an upset stomach. Dietitians share which foods to eat and ...
However, he says you can often lower your risk of side effects by staying well hydrated, eating smaller meals, and limiting processed foods, high-fat foods, and refined carbohydrates.
The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...
Here are some foods you may want to avoid: Fried foods. Greasy foods. Sugary foods and drinks ... this can end up piling onto the gastrointestinal side effects. Plus, these foods can be calorie ...
A gluten-free diet is a diet that strictly excludes gluten, proteins present in wheat (and all wheat varieties such as spelt and kamut), barley, rye, oat, and derivatives of these grains such as malt and triticale, and foods that may include them, or shared transportation or processing facilities with them.
Tremelimumab is indicated, in combination with durvalumab, for the treatment of adults with unresectable hepatocellular carcinoma. [7] [11] [8]Tremelimumab in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer with no sensitizing epidermal growth factor receptor mutations or anaplastic ...
Good news: The foods less likely to trigger side effects from Ozempic are also more likely to boost weight loss. monstArrr_ / iStock The following foods are best when taking Ozempic or semaglutide:
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. [5] [6] [10] Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.